Company intelligence / Profile preview

Pioneer Pharmaceutical

Sulaymaniyah, Sulaymaniyah, Iraq

Ownership: Private
Employees: ~1350
Development stage: Other

Overview

Leading manufacturer of branded and generic medicines in Iraq; first in Iraq with GMP certification, strong private market leader since 2022; expansive manufacturing and regional distribution capacity.

Therapeutic areas: CardiovascularImmunologyOphthalmologyGastroenterologyNeurologyInfectious DiseasesPulmonologyMetabolic DisordersOther
Modalities: Small moleculeBiologicInjectableGeneral FormulationsCephalosporinsPenemsEye drops
Industry: Biotech

Drug pipeline

2 assets

Abipros

Unknown

1 more asset in the full pipeline.

Request access →

Partnerships

Local health authorities (Ministry of Health, Iraq)Kemadia (Iraqi medical procurement agency)International machinery suppliers for Blow-Fill-Seal (BFS) technology

Beyond the preview

Go deeper on Pioneer Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pioneer Pharmaceutical.

Explore the full profile